Carl Zeiss Meditec AG achieves strong revenue and EBIT growth in first three months 2018/19
JENA/Germany | 14 January 2019 | Carl Zeiss Meditec AG
Carl Zeiss Meditec (ISIN: DE0005313704) has achieved revenue of approximately EUR 324 million in the first three months of fiscal year 2018/19, based on preliminary data. This corresponds to revenue growth of around 10% vs. the previous year’s value of EUR 294.7 million. Currency effects only had a minor impact on growth.
In the same period, earnings before interest and taxes (EBIT) increased significantly to EUR 48.1 million (prev. year EUR 38.9 million). This corresponds to an EBIT margin (EBIT in percent of revenue) of 14.9% (prev. year 13.2%). EBIT was positively impacted by temporarily reduced research & development expenses. For fiscal year 2018/19, the company still expects an EBIT margin between 14% to 16%.
The 3-months quarterly statement for fiscal year 2018/19 will be published on February 11, 2019.